Cancer is a complex disease that develops through the multi-stage carcinogenesis process involving multiple pathways. As a result, there are various hurdles associated with cancer diagnosis, prognosis, and therapy. Cancer is the second-leading cause of death worldwide and accounted for 10 million deaths in 2020. Globally, about 1 in 6 deaths occur due to cancer... Continue Reading →

As per the recently published report by MarketsandMarket™, The report "Respiratory Diagnostics Market by Product & Services (Devices, Reagents, Software), Test (PFT, Peak Flow, Spirometry), OSA, Imaging (X-ray, CT, MRI, PET), Molecular (PCR, DNA Sequencing), Indication (Lung Cancer, Asthma, COPD, TB) - Global Forecast to 2029", is expected to reach USD 8.2 billion by 2029 from USD... Continue Reading →

The Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. The global metagenomic sequencing market in terms of revenue was estimated... Continue Reading →

Factors such as growing demand for technologically advanced solutions, rising funding initiatives for improving HCIT infrastructure increase in the number of surgical procedures, , rise on  emphasis on cost control and  improvement in hospitals operations are aiding to the posticve growth of this market. However, interoperability issues the high setup and operational costs, and shortage of... Continue Reading →

The growth of the Amniotic Products market is majorly driven by rising awareness programs for wound care treatment and management and venture capital investments and government funding. However, competition from alternative therapies may challenge the growth of this market. The report Amniotic Products Market is projected to reach USD 1,289 million by 2028 from USD 900... Continue Reading →

The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.6% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus... Continue Reading →